Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 41.230
Filtrer
1.
Crit Rev Ther Drug Carrier Syst ; 42(1): 55-88, 2025.
Article de Anglais | MEDLINE | ID: mdl-39321332

RÉSUMÉ

Enzymes play a pivotal role in the human body, but their potential is not limited to just that. Scientists have successfully modified these enzymes as nanobiocatalysts or nanozymes for industrial or commercial use, either in the food, medicine, biotech or even textile industries. These nanobiocatalysts and nanozymes offer several advantages over enzymes, like better stability, improved shelf-life, increased percentage yield, and reuse potential, which is very difficult with normal enzymes. The various techniques of NBC synthesis using immobilization techniques like adsorption, covalent binding, affinity immobilization, and entrapment methods are briefly discussed. The enzymes are either entrapped or adsorbed on the nanocarrier matrices, which can be nanofibers, nanoporous carriers, or nanocontainers as nanobiocatalysts. We also highlight the challenges the nanobiocatalyst overcomes in the industrial production of some drugs like sitagliptin, montelukast, pregabalin, and atorvastatin. Also, the inactivation of an organophosphate or opioid poisoning treating agent, SSOPOX nanohybrid, is discussed in this paper. Nanozymes are intrinsic enzyme-like compounds, and they also show wide application in themselves. Their GQD/AGNP nanohybrid shows antibacterial potential; they can also be utilized in optical sensing to detect small molecules, ions, nucleic acids, proteins, and cancer cells. In this paper, various applications of these NBCs have been discussed, and their potential applications with examples are also mentioned. Nanoenzymes can address targeted drug delivery via the controlled release of drugs to increase the efficacy of anticancer drugs that minimize damage to healthy tissue or cells.


Sujet(s)
Développement de médicament , Humains , Développement de médicament/méthodes , Biocatalyse , Enzymes immobilisées/composition chimique , Techniques de biocapteur/méthodes , Animaux , Nanoparticules/composition chimique , Nanotechnologie/méthodes , Vecteurs de médicaments/composition chimique , Nanostructures/composition chimique
2.
J Infect Public Health ; 17(10): 102536, 2024 Oct.
Article de Anglais | MEDLINE | ID: mdl-39276432

RÉSUMÉ

The advancement of safe, eco-friendly, and cost-efficient techniques for nanoparticle production is a crucial objective in nanotechnology. Among the various sustainable methods, the biological synthesis of nanoparticles utilizing fungi, bacteria, yeasts, and plants stands out. Fungi, in particular, are well suited for this task because of their capacity to secrete numerous enzymes and streamline subsequent processes. Using fungal strains for nanoparticle biosynthesis is both technologically appealing and economically viable. The utilization of fungal strains for nanoparticle biosynthesis is both technologically appealing and economically viable. Fungi have long been acknowledged as adept natural engineers capable of creating a wide array of nanoparticles with distinct properties and applications. This article provides an overview of fungus-mediated nanoparticle development, shedding light on the underlying mechanisms of their synthesis and the factors influencing their characteristics. Furthermore, the potential of fungus-mediated nanoparticles in the industrial domain has been explored. These findings emphasize the importance of different fungal species in nanoparticle synthesis, as well as the biocompatibility and environmental friendliness of fungus-mediated nanoparticles. By underscoring the essential role of fungi in connecting natural knowledge with innovative industrial applications, recent progress in enhancing nanoparticle production and optimizing synthesis conditions through fungi has been examined to underscore the feasibility of extensive industrial nanoparticle utilization via fungi.


Sujet(s)
Champignons , Nanoparticules , Nanoparticules/composition chimique , Champignons/métabolisme , Nanotechnologie/méthodes
3.
AAPS PharmSciTech ; 25(7): 212, 2024 Sep 07.
Article de Anglais | MEDLINE | ID: mdl-39242428

RÉSUMÉ

UV radiation causes long- and short-term skin damage, such as erythema and skin cancer. Therefore, the use of sunscreens is extremely important. However, concerns about UV filter safety have prompted exploration into alternative solutions, with nanotechnology emerging as a promising avenue. This systematic review identified 23 experimental studies utilizing nanocarriers to encapsulate sunscreens with the aim of enhancing their efficacy and safety. Polymeric and lipid nanoparticles are frequently employed to encapsulate both organic and inorganic UV filters along with natural antioxidants. Nanocarriers have demonstrated benefits including reduced active ingredient usage, increased sun protection factor, and mitigated photoinstability. Notably, they also decreased the skin absorption of UV filters. In summary, nanocarriers represent a viable strategy for improving sunscreen formulations, offering enhanced physicochemical properties and bolstered photoprotective effects, thereby addressing concerns regarding UV filter safety and efficacy in cosmetic applications.


Sujet(s)
Nanoparticules , Nanotechnologie , Produits antisolaires , Rayons ultraviolets , Animaux , Humains , Antioxydants/administration et posologie , Antioxydants/composition chimique , Antioxydants/pharmacologie , Vecteurs de médicaments/composition chimique , Lipides/composition chimique , Nanoparticules/composition chimique , Nanotechnologie/méthodes , Polymères/composition chimique , Peau/métabolisme , Peau/effets des médicaments et des substances chimiques , Absorption cutanée/effets des médicaments et des substances chimiques , Indice de protection solaire , Produits antisolaires/composition chimique , Produits antisolaires/administration et posologie , Rayons ultraviolets/effets indésirables
4.
Ther Deliv ; 15(9): 717-735, 2024.
Article de Anglais | MEDLINE | ID: mdl-39259258

RÉSUMÉ

Apigenin, a potent natural flavonoid, has emerged as a key therapeutic agent due to its multifaceted medicinal properties in combating various diseases. However, apigenin's clinical utility is greatly limited by its poor water solubility, low bioavailability and stability issues. To address these challenges, this review paper explores the innovative field of nanotechnology-based delivery systems, which have shown significant promise in improving the delivery and effectiveness of apigenin. This paper also explores the synergistic potential of co-delivering apigenin with conventional therapeutic agents. Despite the advantageous properties of these nanoformulations, critical challenges such as scalable production, regulatory approvals and comprehensive long-term safety assessments remain key hurdles in their clinical adoption which must be addressed for commercialization of apigenin-based formulations.


Apigenin is a natural substance found in plants that might help treat illnesses like cancer, diabetes, heart problems and brain disorders. But it doesn't work very well because it doesn't dissolve in water, is hard for the body to use and isn't very stable. To fix this, scientists are putting apigenin inside tiny carriers called nanocarriers. These tiny carriers help apigenin dissolve better, be absorbed by the body more easily and work better.There are different kinds of nanocarriers, like tiny fat bubbles, tiny solid particles and tiny gels. These can be made to target specific parts of the body, which helps reduce side effects. Apigenin can also be mixed with other medicines in these carriers to work even better.However, there are big challenges in making these treatments widely available, like making enough of them, getting permission from health authorities and making sure they are safe for a long time. This review talks about the latest progress and future possibilities in using nanotechnology to deliver apigenin, aiming to make it better for treating diseases.


Sujet(s)
Apigénine , Apigénine/administration et posologie , Apigénine/composition chimique , Apigénine/pharmacocinétique , Apigénine/pharmacologie , Humains , Animaux , Biodisponibilité , Solubilité , Systèmes de délivrance de médicaments/méthodes , Nanoparticules/composition chimique , Nanotechnologie/méthodes , Système d'administration de médicaments à base de nanoparticules/composition chimique
5.
Nat Commun ; 15(1): 7894, 2024 Sep 10.
Article de Anglais | MEDLINE | ID: mdl-39256353

RÉSUMÉ

Allostery is a hallmark of cellular function and important in every biological system. Still, we are only starting to mimic it in the laboratory. Here, we introduce an approach to study aspects of allostery in artificial systems. We use a DNA origami domino array structure which-upon binding of trigger DNA strands-undergoes a stepwise allosteric conformational change. Using two FRET probes placed at specific positions in the DNA origami, we zoom in into single steps of this reaction cascade. Most of the steps are strongly coupled temporally and occur simultaneously. Introduction of activation energy barriers between different intermediate states alters this coupling and induces a time delay. We then apply these approaches to release a cargo DNA strand at a predefined step in the reaction cascade to demonstrate the applicability of this concept in tunable cascades of mechanochemical coupling with both spatial and temporal control.


Sujet(s)
ADN , Transfert d'énergie par résonance de fluorescence , Conformation d'acide nucléique , ADN/composition chimique , ADN/métabolisme , Régulation allostérique , Nanotechnologie/méthodes , Nanostructures/composition chimique
7.
STAR Protoc ; 5(3): 103299, 2024 Sep 20.
Article de Anglais | MEDLINE | ID: mdl-39244756

RÉSUMÉ

Mesoscale to nanoscale three-dimensional (3D) fabrication mostly requires complicated industry processing techniques. Here, we present a protocol for 3D shaping control by solidifying a water-based TiO2 nanofluid drop on a polygonal wettability-patterned surface. We detail the steps for preparing stable TiO2 nanofluid and wettability-patterned surfaces. We then describe the experimental procedure to obtain various and precise 3D morphologies by adjusting the deposited TiO2 nanofluid drop volume. This protocol provides a promising technique for future 3D manufacturing. For complete details on the use and execution of this protocol, please refer to Jiang et al.1.


Sujet(s)
Titane , Mouillabilité , Titane/composition chimique , Nanotechnologie/méthodes , Propriétés de surface , Impression tridimensionnelle , Nanostructures/composition chimique
8.
Adv Exp Med Biol ; 1461: 97-108, 2024.
Article de Anglais | MEDLINE | ID: mdl-39289276

RÉSUMÉ

It has been known that cells have mechanisms to sense and respond to environmental noxiousness and mild temperature changes, such as heat shock response and thermosensitive TRP channels. Meanwhile, new methods of measuring temperature at the cellular level has recently been developed using fluorescent nanothermometers. Among these thermometers, fluorescent polymeric thermometers and fluorescent nanodiamonds excel in the properties required for intracellular thermometry. By using these novel methods to measure the temperature of single cells in cultures and tissues, it was revealed that spontaneous spatiotemporal temperature fluctuations occur within cells. Furthermore, the temperature fluctuations were related to organelles such as mitochondria and cellular and physiological functions, revealing a close relationship between intracellular temperature and cellular functions.


Sujet(s)
Colorants fluorescents , Thermomètres , Humains , Colorants fluorescents/composition chimique , Animaux , Nanodiamants/composition chimique , Température , Nanotechnologie/méthodes , Nanotechnologie/instrumentation , Thermométrie/méthodes , Thermométrie/instrumentation
9.
ACS Sens ; 9(9): 4915-4923, 2024 Sep 27.
Article de Anglais | MEDLINE | ID: mdl-39268764

RÉSUMÉ

This paper presents an aptameric graphene nanosensor for rapid and sensitive measurement of arginine vasopressin (AVP) toward continuous monitoring of critical care patients. The nanosensor is a field-effect transistor (FET) with monolayer graphene as the conducting channel and is functionalized with a new custom-designed aptamer for specific AVP recognition. Binding between the aptamer and AVP induces a change in the carrier density in the graphene and resulting in measurable changes in FET characteristics for determination of the AVP concentration. The aptamer, based on the natural enantiomer D-deoxyribose, possess optimized kinetic binding properties and is attached at an internal position to the graphene for enhanced sensitivity to low concentrations of AVP. Experimental results show that this aptameric graphene nanosensor is highly sensitive (with a limit of detection of 0.3 pM and a resolution of 0.1 pM) to AVP, and rapidly responsive (within 90 s) to both increasing and decreasing AVP concentration changes. The device is also reversable (within 4%), repeatable (within 4%) and reproducible (within 5%) in AVP measurements.


Sujet(s)
Aptamères nucléotidiques , Arginine vasopressine , Techniques de biocapteur , Graphite , Graphite/composition chimique , Humains , Techniques de biocapteur/méthodes , Techniques de biocapteur/instrumentation , Aptamères nucléotidiques/composition chimique , Arginine vasopressine/analyse , Transistors électroniques , Limite de détection , Nanotechnologie/instrumentation , Vasopressines/analyse , Monitorage physiologique/méthodes , Monitorage physiologique/instrumentation
10.
Theranostics ; 14(14): 5461-5491, 2024.
Article de Anglais | MEDLINE | ID: mdl-39310098

RÉSUMÉ

Gas therapy, a burgeoning clinical treatment modality, has garnered widespread attention to treat a variety of pathologies in recent years. The advent of nanoscale gas drug therapy represents a novel therapeutic strategy, particularly demonstrating immense potential in the realm of oncology. This comprehensive review navigates the landscape of gases endowed with anti-cancer properties, including hydrogen (H2), carbon monoxide (CO), carbon dioxide (CO2), nitric oxide (NO), oxygen (O2), sulfur dioxide (SO2), hydrogen sulfide (H2S), ozone (O3), and heavier gases. The selection of optimal delivery vectors is also scrutinized in this review to ensure the efficacy of gaseous agents. The paper highlights the importance of engineering stimulus-responsive delivery systems that enable precise and targeted gas release, thereby augmenting the therapeutic efficiency of gas therapy. Additionally, the review examines the synergistic potential of integrating gas therapy with conventional treatments such as starvation therapy, ultrasound (US) therapy, chemotherapy, radiotherapy (RT), and photodynamic therapy (PDT). It also discusses the burgeoning role of advanced multimodal and US imaging in enhancing the precision of gas therapy applications. The insights presented are pivotal in the strategic development of nanomedicine platforms designed for the site-specific delivery of therapeutic gases, heralding a new era in cancer therapeutics.


Sujet(s)
Gaz , Tumeurs , Humains , Tumeurs/thérapie , Tumeurs/diagnostic , Tumeurs/traitement médicamenteux , Animaux , Systèmes de délivrance de médicaments/méthodes , Nanotechnologie/méthodes , Monoxyde de carbone , Antinéoplasiques/administration et posologie , Antinéoplasiques/usage thérapeutique , Nanoparticules/composition chimique , Dioxyde de carbone
11.
J Nanobiotechnology ; 22(1): 573, 2024 Sep 18.
Article de Anglais | MEDLINE | ID: mdl-39294645

RÉSUMÉ

Neurological disorders have for a long time been a global challenge dismissed by drug companies, especially due to the low efficiency of most therapeutic compounds to cross the brain capillary wall, that forms the blood-brain barrier (BBB) and reach the brain. This has boosted an incessant search for novel carriers and methodologies to drive these compounds throughout the BBB. However, it remains a challenge to artificially mimic the physiology and function of the human BBB, allowing a reliable, reproducible and throughput screening of these rapidly growing technologies and nanoformulations (NFs). To surpass these challenges, brain-on-a-chip (BoC) - advanced microphysiological platforms that emulate key features of the brain composition and functionality, with the potential to emulate pathophysiological signatures of neurological disorders, are emerging as a microfluidic tool to screen new brain-targeting drugs, investigate neuropathogenesis and reach personalized medicine. In this review, the advance of BoC as a bioengineered screening tool of new brain-targeting drugs and NFs, enabling to decipher the intricate nanotechnology-biology interface is discussed. Firstly, the main challenges to model the brain are outlined, then, examples of BoC platforms to recapitulate the neurodegenerative diseases and screen NFs are summarized, emphasizing the current most promising nanotechnological-based drug delivery strategies and lastly, the integration of high-throughput screening biosensing systems as possible cutting-edge technologies for an end-use perspective is discussed as future perspective.


Sujet(s)
Barrière hémato-encéphalique , Encéphale , Laboratoires sur puces , Nanotechnologie , Maladies neurodégénératives , Humains , Maladies neurodégénératives/traitement médicamenteux , Maladies neurodégénératives/métabolisme , Barrière hémato-encéphalique/métabolisme , Nanotechnologie/méthodes , Encéphale/métabolisme , Animaux , Systèmes de délivrance de médicaments/méthodes
12.
Microb Cell Fact ; 23(1): 254, 2024 Sep 20.
Article de Anglais | MEDLINE | ID: mdl-39304847

RÉSUMÉ

Bionanofertilizers are promising eco-friendly alternative to chemical fertilizers, leveraging nanotechnology and biotechnology to enhance nutrient uptake by plants and improve soil health. They consist of nanoscale materials and beneficial microorganisms, offering benefits such as enhanced seed germination, improved soil quality, increased nutrient use efficiency, and pesticide residue degradation, ultimately leading to improved crop productivity. Bionanofertilizers are designed for targeted delivery of nutrients, controlled release, and minimizing environmental pollutants, making them a sustainable option for agriculture. These fertilizers also have the potential to enhance plant growth, provide disease resistance, and contribute to sustainable farming practices. The development of bionanofertilizers addresses the adverse environmental impact of chemical fertilizers, offering a safer and productive means of fertilization for agricultural practices. This review provides substantial evidence supporting the potential of bionanofertilizers in revolutionizing agricultural practices, offering eco-friendly and sustainable solutions for crop management and soil health.


Sujet(s)
Agriculture , Engrais , Engrais/analyse , Agriculture/méthodes , Sol/composition chimique , Nanotechnologie/méthodes , Produits agricoles/croissance et développement , Produits agricoles/métabolisme
13.
Nano Lett ; 24(38): 11768-11778, 2024 Sep 25.
Article de Anglais | MEDLINE | ID: mdl-39259830

RÉSUMÉ

DNA encodes genetic information and forms various structural conformations with distinct physical, chemical, and biological properties. Over the past 30 years, advancements in force manipulation technology have enabled the precise manipulation of DNA at nanometer and piconewton resolutions. This mini-review discusses these force manipulation techniques for exploring the mechanical properties of DNA at the single-molecule level. We summarize the distinct mechanical features of different DNA forms while considering the impact of the force geometry. We highlight the role of DNA mechanics in origami structures that serve as self-assembled building blocks or mechanically responsive/active nanomachines. Accordingly, we emphasize how DNA mechanics are integral to the functionality of origami structures for achieving mechanical capabilities. Finally, we provide an outlook on the intrinsic mechanical properties of DNA, from single stranded to self-assembled higher-dimensional structures. This understanding is expected to inspire new design strategies in DNA mechanics, paving the way for innovative applications and technologies.


Sujet(s)
ADN , Nanotechnologie , Conformation d'acide nucléique , ADN/composition chimique , Nanotechnologie/méthodes , Nanostructures/composition chimique , ADN simple brin/composition chimique , Phénomènes biomécaniques
15.
J Am Chem Soc ; 146(38): 26131-26138, 2024 Sep 25.
Article de Anglais | MEDLINE | ID: mdl-39276081

RÉSUMÉ

Creating nanomachines capable of precisely capturing, organizing, and regulating the activity of target biomolecules holds profound significance for advancing nanotechnology and therapeutics. Here, we develop a multistage reconfigurable DNA nanocage that can enclose and modulate proteins through multivalent interactions, activated by specific molecular signals. By strategically designing and manipulating the strut architecture of the DNA nanocages, we can achieve precise control over their reconfiguration among pyramid, square, and linear branch shapes. Additionally, we demonstrated its ability to capture thrombin and effectively inhibit its coagulation activity by incorporating two thrombin-targeting aptamers into the designed arms of the DNA nanocage. The activity of thrombin can be recovered by rearranging the conformation of the DNA nanocage and exposing the protein, thereby activating the coagulation process. This approach enriches the design toolbox for dynamic nanomachines and inspires a new strategy for protein encapsulation and regulation with potential future therapeutic applications.


Sujet(s)
Aptamères nucléotidiques , ADN , Nanostructures , Thrombine , Thrombine/composition chimique , Thrombine/métabolisme , ADN/composition chimique , Nanostructures/composition chimique , Aptamères nucléotidiques/composition chimique , Nanotechnologie/méthodes , Humains
16.
Mol Biol Rep ; 51(1): 958, 2024 Sep 04.
Article de Anglais | MEDLINE | ID: mdl-39230778

RÉSUMÉ

Sheath blight, caused by the fungus Rhizoctonia solani, is a major problem that significantly impacts rice production and can lead to substantial yield losses. The disease has become increasingly problematic in recent years due to the widespread use of high-yielding semi-dwarf rice cultivars, dense planting, and heavy application of nitrogenous fertilizers. The disease has become more challenging to manage due to its diverse host range and the lack of resistant cultivars. Despite utilizing traditional methods, the problem persists without a satisfactory solution. Therefore, modern approaches, including advanced breeding, transgenic methods, genome editing using CRISPR/Cas9 technology, and nanotechnological interventions, are being explored to develop rice plants resistant to sheath blight disease. This review primarily focuses on these recent advancements in combating the sheath blight disease.


Sujet(s)
Biotechnologie , Systèmes CRISPR-Cas , Résistance à la maladie , Édition de gène , Oryza , Amélioration des plantes , Maladies des plantes , Rhizoctonia , Oryza/génétique , Oryza/microbiologie , Maladies des plantes/microbiologie , Maladies des plantes/génétique , Résistance à la maladie/génétique , Rhizoctonia/pathogénicité , Amélioration des plantes/méthodes , Édition de gène/méthodes , Systèmes CRISPR-Cas/génétique , Biotechnologie/méthodes , Végétaux génétiquement modifiés/génétique , Nanotechnologie/méthodes
17.
Anal Chim Acta ; 1324: 343068, 2024 Oct 02.
Article de Anglais | MEDLINE | ID: mdl-39218570

RÉSUMÉ

BACKGROUND: Live single-cell metabolomic studies encounter inherent difficulties attributed to the limited sample volume, minimal compound quantity, and insufficient sensitivity in the Mass Spectrometry (MS) method used to obtain single-cell data. However, understanding cellular heterogeneity, functional diversity, and metabolic processes within individual cells is essential. Exploring how individual cells respond to stimuli, including drugs, environmental changes, or signaling molecules, offers insights into biology, oncology, and drug discovery. Efficient release of cell contents (lysis) is vital for accurate metabolite detection at the single-cell level. Despite this, traditional approaches in live single cell metabolomics methods do not emphasize efficient lysis to prevent sample dilution. Instead, current live single cell metabolomics methods use direct infusion to introduce the cell into the mass spectrometry without prior chromatographic separation or a lysis step, which adversely affects sensitivity and metabolic coverage. RESULTS: To address this, we developed an integrated single-cell electrical lysis and nano spray (SCEL-nS) platform coupled to an Orbitrap MS capable of efficiently lysing a single cell after being sampled with specially manufactured micropipettes. Lysis efficiency was validated by comparing live cell stain fluorescent intensities of intact and electrically lysed cells through microscopy imaging. The SCEL-nS platform successfully induced the breakdown of a single cell, significantly reducing the live cell stain's fluorescent intensity indicating cell membrane breakdown. Additionally, SCEL-nS was validated by measuring single cells spiked with the anti-cancer drug tamoxifen by MS. SCEL-nS use resulted in statistically significant increase in the peak measured by the method compared to the traditional non-lysis method. SIGNIFICANCE: Overall, our results demonstrate that the newly incorporated SCEL-nS platform achieved higher sensitivities compared to traditional live single cell analysis methods.


Sujet(s)
Analyse sur cellule unique , Spectrométrie de masse ESI , Humains , Spectrométrie de masse ESI/méthodes , Nanotechnologie , Métabolomique/méthodes
18.
Water Sci Technol ; 89(2): 454-469, 2024 Jan.
Article de Anglais | MEDLINE | ID: mdl-39219141

RÉSUMÉ

Nanofiltration (NF) has been used as the default sulfate removal process in platforms to treat seawater for water flooding. Seawater is generally pretreated by chlorination and cartridge filters to reduce fouling of the membranes; however, this pretreatment is insufficient to provide water quality high enough to maintain the productivity of the NF membranes. In this study, the performances of two different pretreatment routes were evaluated. Microfiltration (MF) was evaluated as a replacement for cartridge filters, and the advanced oxidation process UV/H2O2 was evaluated as an additional stage of pretreatment upstream of the cartridge filters. The permeability of the NF membranes after 12 h of seawater sulfate removal in a bench system was 4.4 L·h-1·m-2·bar-1 when the UV/H2O2 process was adopted as the pretreatment and 2.9 L·h-1·m-2·bar-1 when the MF process was adopted, compared to 1.6 L·h-1·m-2·bar-1 achieved for the pretreatment with the cartridge filter alone. These results indicate that NF membrane fouling was significantly higher when seawater was pretreated only by the cartridge filter in comparison to both proposed pretreatments. An economic analysis showed that both systems are economically viable and can potentially reduce the operational costs of the NF sulfate removal process on platforms.


Sujet(s)
Filtration , Eau de mer , Purification de l'eau , Purification de l'eau/méthodes , Purification de l'eau/instrumentation , Filtration/méthodes , Filtration/instrumentation , Membrane artificielle , Sulfates/composition chimique , Nanotechnologie , Peroxyde d'hydrogène/composition chimique
19.
AAPS PharmSciTech ; 25(7): 215, 2024 Sep 12.
Article de Anglais | MEDLINE | ID: mdl-39266806

RÉSUMÉ

Neurodegenerative disorder refers to malfunctioning of neurons their degradation leading to death of neurons. Among various neurodegenerative disorders APHD (Alzheimer's, Parkinson's, and Huntington's Disease) are particularly concerning due to their progressive and debilitating nature. The therapeutic agent used for treatment and management of APHD often show unsatisfactory clinical outcome owing to poor solubility and limited permeability across blood brain barrier (BBB). The nose-to brain delivery can overcome this BBB challenge as it can transport drug directly to brain though olfactory pathways bypassing BBB. Additionally, the nanotechnology has emerged as a cutting-edge methodology to address this issue and specifically mucoadhesive micro/nanoemulsion can improve the overall performance of the drug when administered intranasally. Beyond the therapy neurotechnology has emerged as are revolutionary AI-driven BCI (Brain computer interface) aimed to restore independence in patients with function loss due to neuron degeneration/death. A promising BCI Neuralink has been recently explored for clinical trials and results revealed that a quadriplegia bearing person with implanted Neuralink chip was able to perform few normal functions of daily routine such as playing online games, text messaging, reading, and learning foreign languages online through accessing the particular websites. This review will discuss the fundamental concepts of neurodegeneration, application of micro/nanoemulsion through intranasal route and integration of neurotechnology for the management and treatment of APHD.


Sujet(s)
Administration par voie nasale , Systèmes de délivrance de médicaments , Émulsions , Nanotechnologie , Maladies neurodégénératives , Administration par voie nasale/méthodes , Humains , Maladies neurodégénératives/traitement médicamenteux , Maladies neurodégénératives/métabolisme , Systèmes de délivrance de médicaments/méthodes , Nanotechnologie/méthodes , Animaux , Barrière hémato-encéphalique/métabolisme , Nanoparticules/composition chimique , Nanoparticules/administration et posologie
20.
Biochim Biophys Acta Mol Basis Dis ; 1870(8): 167486, 2024 Dec.
Article de Anglais | MEDLINE | ID: mdl-39218275

RÉSUMÉ

Tumors pose a major threat to human health, accounting for nearly one-sixth of global deaths annually. The primary treatments include surgery, radiotherapy, chemotherapy, and immunotherapy, each associated with significant side effects. This has driven the search for new therapies with fewer side effects and greater specificity. Nanotechnology has emerged as a promising field in this regard, particularly nanomolecular machines at the nanoscale. Nanomolecular machines are typically constructed from biological macromolecules like proteins, DNA, and RNA. These machines can be programmed to perform specialized tasks with precise instructions. Recent research highlights their potential in tumor diagnostics-identifying susceptibility genes, detecting viruses, and pinpointing tumor markers. Nanomolecular machines also offer advancements in tumor therapy. They can reduce traditional treatment side effects by delivering chemotherapy drugs and enhancing immunotherapy, and they support innovative treatments like sonodynamic and phototherapy. Additionally, they can starve tumors by blocking blood vessels, and eliminate tumors by disrupting cell membranes or lysosomes. This review categorizes and explains the latest achievements in molecular machine research, explores their models, and practical clinical uses in tumor diagnosis and treatment. It aims to broaden the research perspective and accelerate the clinical adoption of these technologies.


Sujet(s)
Tumeurs , Médecine de précision , Humains , Tumeurs/thérapie , Tumeurs/diagnostic , Tumeurs/génétique , Médecine de précision/méthodes , Immunothérapie/méthodes , Nanotechnologie/méthodes , Nanomédecine/méthodes , Animaux , Antinéoplasiques/usage thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE